Differential expression of oct4 variants and pseudogenes in normal urothelium and urothelial cancer

American Journal of Pathology

Volumn 183, Issue 4, 2013, Pages 1128-1136

  Wezel, Felix ^a,b   Pearson, Joanna ^a   Kirkwood, Lisa A ^a   Southgate, Jennifer ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR SOX2;

ANTIBODY LABELING; ARTICLE; BLADDER CANCER; CANCER STEM CELL; CELL CYCLE; EMBRYO DEVELOPMENT; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IN VITRO STUDY; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CANCER; UROTHELIAL CANCER; UROTHELIUM; WESTERN BLOTTING;

CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; OCTAMER TRANSCRIPTION FACTOR-3; PSEUDOGENES; SOXB1 TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84884562854     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.06.025     Document Type: Article

References (31)

1. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
2. J.B. Kim, V. Sebastiano, G. Wu, M.J. Araúzo-Bravo, P. Sasse, L. Gentile, K. Ko, D. Ruau, M. Ehrich, D. van den Boom, J. Meyer, K. Hübner, C. Bernemann, C. Ortmeier, M. Zenke, B.K. Fleischmann, H. Zaehres, and H.R. Schöler Oct4-induced pluripotency in adult neural stem cells Cell 136 2009 411 419
3. Y. Atlasi, S.J. Mowla, S.A. Ziaee, and A.R. Bahrami OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer Int J Cancer 120 2007 1598 1602
4. U.I. Ezeh, P.J. Turek, R.A. Reijo, and A.T. Clark Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma Cancer 104 2005 2255 2265
5. C.J. Lengner, F.D. Camargo, K. Hochedlinger, G.G. Welstead, S. Zaidi, S. Gokhale, H.R. Scholer, A. Tomilin, and R. Jaenisch Oct4 expression is not required for mouse somatic stem cell self-renewal Cell Stem Cell 1 2007 403 415
6. T. Cantz, G. Key, M. Bleidissel, L. Gentile, D.W. Han, A. Brenne, and H.R. Schöler Absence of OCT4 expression in somatic tumor cell lines Stem Cells 26 2008 692 697
7. G. Suo, J. Han, X. Wang, J. Zhang, Y. Zhao, and J. Dai Oct4 pseudogenes are transcribed in cancers Biochem Biophys Res Commun 337 2005 1047 1051
8. S. Liedtke, J. Enczmann, S. Waclawczyk, P. Wernet, and G. Kögler Oct4 and its pseudogenes confuse stem cell research [Erratum appeared in Cell Stem Cell 2008, 2:190] Cell Stem Cell 1 2007 364 366
9. X. Wang, and J. Dai Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology Stem Cells 28 2010 885 893
10. M.H. Asadi, S.J. Mowla, F. Fathi, A. Aleyasin, J. Asadzadeh, and Y. Atlasi OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor Int J Cancer 128 2011 2645 2652
11. Y. Atlasi, S.J. Mowla, S.A. Ziaee, P.J. Gokhale, and P.W. Andrews OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells Stem Cells 26 2008 3068 3074
12. Y. Gao, X. Wang, J. Han, Z. Xiao, B. Chen, G. Su, and J. Dai The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B J Genet Genomics 37 2010 461 465
13. X. Wang, Y. Zhao, Z. Xiao, B. Chen, Z. Wei, B. Wang, J. Zhang, J. Han, Y. Gao, L. Li, H. Zhao, W. Zhao, H. Lin, and J. Dai Alternative translation of OCT4 by an internal ribosome entry site and its novel function in stress response Stem Cells 27 2009 1265 1275
14. J. Sterneckert, S. Höing, and H.R. Schöler Concise review: Oct4 and more: the reprogramming expressway Stem Cells 30 2012 15 21
15. A. Stenzl, N.C. Cowan, M. De Santis, M.A. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, and J.A. Witjes European Association of Urology (EAU): Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines Eur Urol 59 2011 1009 1018
16. P. Jeong, Y.S. Ha, I.C. Cho, S.J. Yun, E.S. Yoo, I.Y. Kim, Y.H. Choi, S.K. Moon, and W.J. Kim Three-gene signature predicts disease progression of non-muscle invasive bladder cancer Oncol Lett 2 2011 679 684
17. X. He, L. Marchionni, D.E. Hansel, W. Yu, A. Sood, J. Yang, G. Parmigiani, W. Matsui, and D.M. Berman Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma Stem Cells 27 2009 1487 1495
18. K.S. Chan, I. Espinosa, M. Chao, D. Wong, L. Ailles, M. Diehn, H. Gill, J. Presti Jr., H.Y. Chang, M. van de Rijn, L. Shortliffe, and I.L. Weissman Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells Proc Natl Acad Sci USA 106 2009 14016 14021
19. Z. Zhu, J. Wen, X. Zheng, D. Wang, Q. Wang, and C. Fan Expression of transcription factor Oct4 in bladder cancer cell line T24 and its effects on the biological characteristics of the cells J Huazhong Univ Sci Technolog Med Sci 29 2009 73 76
20. J. Nichols, B. Zevnik, K. Anastassiadis, H. Niwa, D. Klewe-Nebenius, I. Chambers, H. Schöler, and A. Smith Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4 Cell 95 1998 379 391
21. P. Huang, J. Chen, L. Wang, Y. Na, H. Kaku, H. Ueki, K. Sasaki, K. Yamaguchi, K. Zhang, T. Saika, Y. Nasu, M. Watanabe, and H. Kumon Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence Med Oncol 29 2012 829 834
22. J. Southgate, J.R. Masters, and L.K. Trejdosiewicz Culture of human urothelium. Culture of Epithelial Cells, ed 2 R.I. Freshney, M.G. Freshney, 2002 John Wiley & Sons New York 381 400
23. T. Mueller, J. Luetzkendorf, K. Nerger, H.J. Schmoll, and L.P. Mueller Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells Cell Mol Life Sci 66 2009 495 503
24. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
25. I.H. Park, R. Zhao, J.A. West, A. Yabuuchi, H. Huo, T.A. Ince, P.H. Lerou, M.W. Lensch, and G.Q. Daley Reprogramming of human somatic cells to pluripotency with defined factors Nature 451 2008 141 146
26. N.T. Georgopoulos, L.A. Kirkwood, D.C. Walker, and J. Southgate Differential regulation of growth-promoting signalling pathways by E-cadherin PLoS One 5 2010 e13621
27. S. Zhao, Q. Yuan, H. Hao, Y. Guo, S. Liu, Y. Zhang, J. Wang, H. Liu, F. Wang, K. Liu, E.A. Ling, and A. Hao Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma J Pathol 223 2011 672 682
28. M.A. Rijlaarsdam, H.A. van Herk, A.J. Gillis, H. Stoop, G. Jenster, J. Martens, G.J. van Leenders, W. Dinjens, A.M. Hoogland, M. Timmermans, and L.H. Looijenga Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours [Erratum appeared in Br J Cancer 2012, 106:791] Br J Cancer 105 2011 854 863
29. I. Panagopoulos, E. Möller, A. Collin, and F. Mertens The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1 isoform 1 Oncol Rep 20 2008 1029 1033
30. B. Liao, and Y. Jin Wwp2 mediates Oct4 ubiquitination and its own auto-ubiquitination in a dosage-dependent manner Cell Res 20 2010 332 344
31. S. Kastler, L. Honold, M. Luedeke, R. Kuefer, P. Möller, J. Hoegel, W. Vogel, C. Maier, and G. Assum POU5F1P1, a putative cancer susceptibility gene, is overexpressed in prostatic carcinoma Prostate 70 2010 666 674